|
|
Small Wonder: Nanoparticle Strategies for Biological Drugs
- Article from:
-
Pharmaceutical Technology
- Article date:
-
June 1, 2008
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Nanoparticle-based systems present many advantages for the delivery of current and emerging biological drugs.
Anyone keeping abreast of industry trends in the pharmaceutical market has noticed the enthusiasm that drug developers, investors, and even traditional pharmaceutical companies have for biological drugs. Motivated as much by the technical and therapeutic promise of biologicals as by a diminished number of small-drug candidates in their pipelines, mainstream pharmaceutical companies are increasingly betting on large-molecule, biotechnically derived drugs.
In spite of their clinical promise and market potential, biological drugs present unique challenges for drug formulators and ...